Literature DB >> 29626008

Differences between ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications performance in identifying cytological high-risk thyroid nodules.

A Lauria Pantano1, E Maddaloni2, S I Briganti2, G Beretta Anguissola2, E Perrella3, C Taffon3, A Palermo2, P Pozzilli2, S Manfrini2, A Crescenzi3.   

Abstract

OBJECTIVE: Thyroid ultrasound is crucial for clinical decision in the management of thyroid nodules. In this study, we aimed to estimate and compare the performance of ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications in discriminating nodules with high-risk cytology.
DESIGN: Cross-sectional study.
METHODS: 1077 thyroid nodules undergoing fine-needle aspiration were classified according to ATA, AACE/ACE/AME and ACR TI-RADS ultrasound classifications by an automated algorithm. Odds ratios (ORs) and receiver operating characteristic (ROC) curves for high-risk cytology categories (TIR3b, TIR4 and TIR5) were calculated for the different US categories and compared.
RESULTS: Cytological categories of risk increased together with all US classifications' sonographic patterns (P < 0.001). The diagnostic performance (C-index) of ACR TI-RADS and AACE/ACE/AME significantly improved when adding clinical data as gender and age in the regression model (P < 0.001). A significant difference in the final model C-index between the three US classification systems was found (P < 0.029), with the ACR TI-RADS showing the highest nominal C-index value, significantly superior to ATA (P = 0.008), but similar to AACE/ACE/AME (P = 0.287). ATA classification was not able to classify 54 nodules, which showed a significant 7 times higher risk of high-risk cytology than the 'very low suspicion' nodules (OR: 7.20 (95% confidence interval: 2.44-21.24), P < 0.001).
CONCLUSIONS: The ACR TI-RADS classification system has the highest area under the ROC curve for the identification of cytological high-risk nodules. ATA classification leaves 'unclassified' nodules at relatively high risk of malignancy.
© 2018 European Society of Endocrinology.

Entities:  

Mesh:

Year:  2018        PMID: 29626008     DOI: 10.1530/EJE-18-0083

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  27 in total

1.  Comparison and preliminary discussion of the reasons for the differences in diagnostic performance and unnecessary FNA biopsies between the ACR TIRADS and 2015 ATA guidelines.

Authors:  Xiao-Li Wu; Jia-Rui Du; Hui Wang; Chun-Xiang Jin; Guo-Qing Sui; Dong-Yan Yang; Yuan-Qiang Lin; Qiang Luo; Ping Fu; He-Qun Li; Deng-Ke Teng
Journal:  Endocrine       Date:  2019-03-04       Impact factor: 3.633

2.  Discordance Between the American Thyroid Association and the American College of Radiology Guideline Systems for Thyroid Nodule Biopsy.

Authors:  Eric Kim; Roshini Pudhucode; Herbert Chen; Brenessa Lindeman
Journal:  J Surg Res       Date:  2020-07-01       Impact factor: 2.192

3.  Learnability and reproducibility of ACR Thyroid Imaging, Reporting and Data System (TI-RADS) in postgraduate freshmen.

Authors:  Dengke Teng; Ping Fu; Wenjia Li; Feng Guo; Hui Wang
Journal:  Endocrine       Date:  2020-01-09       Impact factor: 3.633

Review 4.  Thyroid Nodule Evaluation and Management in Older Adults: A Review of Practical Considerations for Clinical Endocrinologists.

Authors:  Naykky Singh Ospina; Maria Papaleontiou
Journal:  Endocr Pract       Date:  2021-02-12       Impact factor: 3.443

5.  BRAFV600E mutation combined with American College of Radiology thyroid imaging report and data system significantly changes surgical resection rate and risk of malignancy in thyroid cytopathology practice.

Authors:  Yun Zhu; Hongxun Wu; Botao Huang; Xin Shen; Gangming Cai; Xiaobo Gu
Journal:  Gland Surg       Date:  2020-10

6.  Usefulness of Color Doppler Ultrasonography in the Risk Stratification of Thyroid Nodules.

Authors:  Ernesto Maddaloni; Silvia Irina Briganti; Anna Crescenzi; Giuseppina Beretta Anguissola; Eleonora Perrella; Chiara Taffon; Andrea Palermo; Silvia Manfrini; Paolo Pozzilli; Angelo Lauria Pantano
Journal:  Eur Thyroid J       Date:  2020-08-19

7.  Comparison of different systems of ultrasound (US) risk stratification for malignancy in elderly patients with thyroid nodules. Real world experience.

Authors:  Fernando Di Fermo; Noelia Sforza; Melanie Rosmarin; Yanina Morosan Allo; Carina Parisi; Jimena Santamaria; Nestor Pacenza; Carlos Zuk; Cristina Faingold; Florencia Ferraro; Tomas Meroño; Gabriela Brenta
Journal:  Endocrine       Date:  2020-04-14       Impact factor: 3.633

8.  Risk of Malignancy (ROM) of Thyroid FNA Diagnosed as Suspicious for Malignancy or Malignant: an Institutional Experience with Systematic Review and Meta-Analysis of Literature.

Authors:  Pierpaolo Trimboli; Franco Fulciniti; Gaetano Paone; Jessica Barizzi; Arnoldo Piccardo; Elisabetta Merlo; Luca Mazzucchelli; Luca Giovanella
Journal:  Endocr Pathol       Date:  2020-03       Impact factor: 3.943

9.  Qualitative analysis of contrast-enhanced ultrasound in the diagnosis of small, TR3-5 benign and malignant thyroid nodules measuring ≤1 cm.

Authors:  Xin Li; Feng Gao; Fan Li; Xiao-Xia Han; Si-Hui Shao; Ming-Hua Yao; Chun-Xiao Li; Jun Zheng; Rong Wu; Lian-Fang Du
Journal:  Br J Radiol       Date:  2020-04-09       Impact factor: 3.039

10.  Evaluation of the Diagnostic Performance of EU-TIRADS in Discriminating Benign from Malignant Thyroid Nodules: A Prospective Study in One Referral Center.

Authors:  Roussanka D Kovatcheva; Alexander D Shinkov; Inna D Dimitrova; Ralitsa B Ivanova; Kalin N Vidinov; Radina S Ivanova
Journal:  Eur Thyroid J       Date:  2020-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.